Microbial and inflammatory-based salivary biomarkers of head and neck squamous cell carcinoma

被引:52
|
作者
Vesty, Anna [1 ]
Gear, Kim [2 ]
Biswas, Kristi [1 ]
Radcliff, Fiona J. [3 ]
Taylor, Michael W. [4 ,5 ]
Douglas, Richard G. [1 ]
机构
[1] Univ Auckland, Dept Surg, Level 12 Auckland City Hosp Support Bldg,2 Pk Rd, Auckland 1023, New Zealand
[2] Auckland Dist Hlth Board, Otorhinolaryngol, Auckland, New Zealand
[3] Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand
[4] Univ Auckland, Sch Biol Sci, Auckland, New Zealand
[5] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand
来源
关键词
cytokines; head and neck cancer; oral microbiome; oral mycobiome; saliva;
D O I
10.1002/cre2.139
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Head and neck squamous cell carcinoma (HNSCC) patients often present with poor oral health, making it difficult to assess the relationship between oral microbes, inflammation, and carcinoma. This study investigates salivary microbes and inflammatory cytokines as biomarkers for HNSCC, with consideration of oral health. Saliva was collected from 30 participants, including 14 HNSCC patients and 16 participants representing both dentally compromised and healthy individuals. Bacterial and fungal communities were analyzed based on 16S rRNA gene and ITS1 amplicon sequencing, respectively, and concentrations of inflammatory cytokines were quantified using a cytometric bead array, with flow cytometry. Diversity-based analyses revealed that the bacterial communities of HNSCC patients were significantly different to those of the healthy control group but not the dentally compromised patients. Fungal communities were dominated by Candida, irrespective of cohort, with Candida albicans comprising >= 96% of fungal sequences in most HNSCC patients. Significantly higher concentrations of interleukin (IL)-1 beta and IL-8 were detected in HNSCC and dentally compromised patients, when independently compared with healthy controls. IL-1 beta and IL-8 concentrations were significantly positively correlated with the abundance of C. albicans. Our findings suggest that salivary microbial and inflammatory biomarkers of HNSCC are influenced by oral health.
引用
收藏
页码:255 / 262
页数:8
相关论文
共 50 条
  • [41] CANCER STEM CELL RELATED BIOMARKERS OF RADIORESISTANCE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Kurth, I.
    Nykytenko, A.
    Baumann, M.
    Dubrovska, A.
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 : 31 - 31
  • [42] Resistance biomarkers in patients with head and neck squamous cell carcinoma treated with cetuximab
    Kamal, Maud
    Leblanc, Olivia
    Vacher, Sophie
    Lecerf, Charlotte
    Jeannot, Emmanuelle
    Klijanienko, Jerzy
    Berger, Frederique
    Hoffmann, Caroline
    Calugaru, Valentin
    Badois, Nathalie
    Chilles, Anne
    Lesnik, Maria
    Krhili, Samar
    Jouffroy, Thomas
    Bieche, Ivan
    Le Tourneau, Christophe
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Predictive biomarkers and EGFR inhibitors in squamous cell carcinoma of head and neck (SCCHN)
    Vigneswara, V.
    Kong, A.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 794 - 796
  • [44] Impact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinoma
    Tower, Jacob I.
    Lingen, Mark W.
    Seiwert, Tanguy Y.
    Langerman, Alexander
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2014, 6 (05): : 548 - 557
  • [45] The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma
    Ma, Chao
    Li, Haoyu
    Li, Xian
    Lu, Shuwen
    He, Jianfeng
    BIOMARKERS IN MEDICINE, 2019, 13 (16) : 1399 - 1415
  • [46] Prognostic value of pretreatment cardiovascular biomarkers in head and neck squamous cell carcinoma
    de Oliveira, Karine Gadioli
    Thebit, Marcela Marcal
    Andrade, Tadeu Uggere
    Campos, Fabiana Vasconcelos
    Podesta, Jose Roberto Vasconcelos
    Zeidler, Sandra Lucia Ventorin Von
    Bissoli, Nazare Souza
    Gouvea, Sonia Alves
    ORAL DISEASES, 2021, 27 (06) : 1435 - 1442
  • [47] Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy
    Saini, Kamal S.
    Somara, Sasikala
    Ko, Heidi C.
    Thatai, Purva
    Quintana, Angela
    Wallen, Zachary D.
    Green, Michelle F.
    Mehrotra, Ravi
    Mcguigan, Sandra
    Pang, Lingjuan
    Das, Soma
    Yadav, Kavita
    Neric, Dobrica
    Cantini, Luca
    Joshi, Chinmayee
    Iwamoto, Kazuya
    Dubbewar, Sudha
    Vidal, Laura
    Chico, Isagani
    Severson, Eric
    Lorini, Luigi
    Badve, Sunil
    Bossi, Paolo
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [48] Utility of miRNA biomarkers for detection of early head and neck squamous cell carcinoma
    Ershadifar, Soroush
    Young, Kurtis
    Birkeland, Andrew C.
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (03) : 673 - 675
  • [49] Novel biomarkers for head and neck squamous cell carcinoma: A retrospective study.
    Dou, Shengjin
    Zhang, Lin
    Li, Rongrong
    Sun, Debin
    Wu, Lijia
    Zhu, Guopei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers
    Swiecicki, Paul L.
    Brennan, Julia R.
    Mierzwa, Michelle
    Spector, Matthew E.
    Brenner, J. Chad
    LARYNGOSCOPE, 2019, 129 (08): : 1836 - 1843